NOVATION CERAMIC ARTICULATION HIP SYSTEM

Prosthesis, Hip, Semi-constrained, Metal/ceramic/ceramic/metal, Cemented Or Uncemented

FDA Premarket Approval P050039

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the novation ceramic articulation hip system. This device is indicated for primary total hip arthroplasty in skeletally mature patients with non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, congenital hip dysplasia, and traumatic arthritis.

DeviceNOVATION CERAMIC ARTICULATION HIP SYSTEM
Classification NameProsthesis, Hip, Semi-constrained, Metal/ceramic/ceramic/metal, Cemented Or Uncemented
Generic NameProsthesis, Hip, Semi-constrained, Metal/ceramic/ceramic/metal, Cemented Or Uncemented
ApplicantEXACTECH, INC.
Date Received2005-10-27
Decision Date2007-07-05
Notice Date2007-07-20
PMAP050039
SupplementS
Product CodeMRA
Docket Number07M-0287
Advisory CommitteeOrthopedic
Expedited ReviewNo
Combination Product No
Applicant Address EXACTECH, INC. 2320 N.w. 66th Ct. gainesville, FL 32653
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P050039Original Filing
S021 2016-09-01 Normal 180 Day Track No User Fee
S020 2016-09-01 30-day Notice
S019 2016-06-24 30-day Notice
S018 2015-12-09 30-day Notice
S017 2015-07-06 Normal 180 Day Track No User Fee
S016 2014-05-20 30-day Notice
S015 2013-01-11 30-day Notice
S014 2012-11-14 30-day Notice
S013 2012-10-04 30-day Notice
S012 2012-09-18 30-day Notice
S011 2012-08-30 30-day Notice
S010 2012-07-24 30-day Notice
S009 2012-03-28 Special (immediate Track)
S008 2012-03-26 135 Review Track For 30-day Notice
S007 2011-10-07 135 Review Track For 30-day Notice
S006
S005 2011-03-11 Special (immediate Track)
S004 2009-09-15 Normal 180 Day Track No User Fee
S003 2009-08-19 30-day Notice
S002 2008-07-31 135 Review Track For 30-day Notice
S001 2007-10-31 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
10885862027078 P050039 000
10885862025289 P050039 000
10885862025296 P050039 000
10885862025302 P050039 000
10885862025319 P050039 000
10885862279026 P050039 000
10885862279033 P050039 000
10885862279040 P050039 000
10885862279057 P050039 000
10885862025272 P050039 000
10885862025265 P050039 000
10885862025258 P050039 000
10885862027139 P050039 000
10885862027207 P050039 000
10885862027214 P050039 000
10885862027221 P050039 000
10885862025210 P050039 000
10885862025227 P050039 000
10885862025234 P050039 000
10885862025241 P050039 000
10885862279064 P050039 000
10885862279071 P050039 000
10885862026026 P050039 000
10885862026033 P050039 000
10885862026040 P050039 000
10885862026057 P050039 000
10885862026361 P050039 000
10885862026422 P050039 000
10885862026484 P050039 000
10885862026491 P050039 000
10885862026019 P050039 000
10885862026002 P050039 000
10885862025999 P050039 000
10885862279088 P050039 000
10885862279095 P050039 000
10885862279101 P050039 000
10885862279118 P050039 000
10885862279125 P050039 000
10885862025968 P050039 000
10885862025975 P050039 000
10885862025982 P050039 000
10885862026507 P050039 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.